Meyka Pro banner
Nuwellis, Inc.

Nuwellis, Inc. (NUWE) Stock Overview

Explore Nuwellis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NUWENASDAQ
HealthcareMedical - Devices
$4.45
$2.56(135.45%)
U.S. Market opens in 10h 40m

Nuwellis, Inc. (NUWE)

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E Ratio-0.00
EPS (TTM)$-2.28
ROE-170.16%
Fundamental Analysis

AI Price Forecasts

1 Month$-6.01
3 Months$1.52
1 Year Target$0.00

NUWE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Nuwellis, Inc. (NASDAQ: NUWE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Nuwellis, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NUWE on the NASDAQ shows an RSI of 70.25, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Nuwellis, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 1.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NUWE on the NASDAQ.

Price Performance (NASDAQ: NUWE)

1-Day Change
135.45%
5-Day Change
102.27%
1-Month Change
45.90%
3-Month Change
-88.75%
6-Month Change
-96.63%
Year-to-Date (YTD) Change
-92.69%
1-Year Change
-98.80%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

952 345 4200
12988 Valley View Road, Eden Prairie, MN, 55344

Company Facts

380 Employees
IPO DateFeb 16, 2012
CountryUS
Actively Trading

Frequently Asked Questions